Recent Articles
Lululemon’s EPS Expected to Climb: What LULU Stock Owners Should Know Ahead of Next Week’s Release
By
LULU possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Owners and prospective buyers of LULU stock should examine these factors.
Facebook, Apple, Amazon, or Netflix: Time to Buy a Few FAANG Stocks Again?
By
Should investors consider buying some FAANG stocks, such as Netflix stock, Facebook, Apple or Amazon?
ULTA Reporting After the Bell Today: Will ULTA Stock Remain a Retail Jewel?
By
ULTA stock has had some strong, positive catalysts, including ULTA's ability to meet the needs of its younger customers.
Nike Stock Is Outpacing the Market: What You Should Know
By
Nike stock closed yesterday at $83.48, gaining 1.77% from the previous trading session. NKE stock is also outpacing the market in early trading today.
Amgen to Buy Celgene’s Otezla for $13.4B: Is the Deal Good for Amgen Stock?
By
Amgen's purchase of Celgenes blockbuster psoriasis drug, Otezla is likely to strengthen its position in the immunology space and boost Amgen stock.
![Louis Navellier's Market 360 logo](https://investorplace.com/wp-content/uploads/2021/10/lnel-logo-new-175x25-1.png)
Join Louis Navellier’s Market 360 — FREE!
Get Louis Navellier’s take on the news and events impacting the market, plus his top stock picks.